pipeline | autoimmune/inflammation | oncology
ALPN-101 is targeted to begin clinical studies in Q1-2019. ALPN-202 is targeted to enter the clinic in Q4-2019
We'll be presenting at the 2018 Stifel Healthcare Conference in a couple of hours. The presentation will be webcast… twitter.com/i/web/status/10625…
November 14, 2018 5:45 am
We had a productive #SITC2018 as we look to improve outcomes for patients with cancer! You can find both our poster… twitter.com/i/web/status/10619…
November 12, 2018 3:01 pm
© 2018 Alpine Immune Sciences. All Rights Reserved, Alpine Immune Sciences Inc.